by Clinical Neuropsychologist Online | Thursday, August 22, 2024 | Neurorehabilitation
Rehabilitation Psychology, Vol 69(4), Nov 2024, 335-346; doi:10.1037/rep0000579Purpose/Objective: Small sample sizes are a common problem in disability research. Here, we show how Bayesian methods can be applied in small sample settings and the advantages that they...
by Clinical Neuropsychologist Online | Thursday, August 22, 2024 | Neuroscience
Psychology & Neuroscience, Vol 17(4), Dec 2024, 336-347; doi:10.1037/pne0000343Objective: In this study, we utilized guppy larvae and juveniles using the plus maze with ramp (PMR) to obtain data on behavior during the early stages of their lives. The goal was to...
by Clinical Neuropsychologist Online | Wednesday, August 21, 2024 | Dementia
Abstract INTRODUCTION CT1812 is in clinical development for the treatment of Alzheimer’s disease (AD). Cerebrospinal fluid (CSF) exploratory proteomics was employed to identify pharmacodynamic biomarkers of CT1812 in mild to moderate AD from two independent...
by Clinical Neuropsychologist Online | Wednesday, August 21, 2024 | Dementia
Abstract Neurogenesis persists throughout adulthood in the hippocampus and contributes to specific cognitive functions. In Alzheimer’s disease (AD), the hippocampus is affected by pathology and functional impairment early in the disease. Human AD patients have...
by Clinical Neuropsychologist Online | Wednesday, August 21, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Sarah Walter, Rochelle Long, Cynthia Huling Hummel | August 21,...
